Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
Center for International Blood and Marrow Transplant Research
University of Washington
Memorial Sloan Kettering Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
National Cancer Institute (NCI)
University Health Network, Toronto
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Incyte Corporation
City of Hope Medical Center
Incyte Corporation
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
University of Alabama at Birmingham
University of Alabama at Birmingham
PharmaEssentia Japan K.K.
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Incyte Corporation
City of Hope Medical Center
PharmaEssentia
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Cogent Biosciences, Inc.
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Italfarmaco
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Istituto Clinico Humanitas
City of Hope Medical Center
M.D. Anderson Cancer Center